Sigma Planning Corp Novo Nordisk A S Transaction History

Sigma Planning Corp

$3.07 Billion
Q4 2024

A detailed history of Sigma Planning Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Sigma Planning Corp holds 11,755 shares of NVO stock, worth $685,669. This represents 0.03% of its overall portfolio holdings.

Number of Shares

11,755

Previous 15,597 24.63%

Holding current value

$685,669

Previous $1.86 Million 45.56%

% of portfolio

0.03%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$85.0 - $120.04 $326,570 - $461,193	-3,842 Reduced 24.63%	11,755 $1.01 Million
Q3 2024 Nov 01, 2024	SELL	$119.07 - $145.42 $115,140 - $140,621	-967 Reduced 5.84%	15,597 $1.86 Million
Q2 2024 Aug 05, 2024	SELL	$122.71 - $146.91 $45,648 - $54,650	-372 Reduced 2.2%	16,564 $2.36 Million
Q1 2024 May 01, 2024	BUY	$102.11 - $135.92 $745,300 - $992,080	7,299 Added 75.74%	16,936 $2.17 Million
Q4 2023 Feb 01, 2024	SELL	$87.78 - $105.45 $168,800 - $202,780	-1,923 Reduced 16.63%	9,637 $996,000
Q3 2023 Nov 06, 2023	BUY	$90.94 - $199.54 $781,538 - $1.71 Million	8,594 Added 289.75%	11,560 $1.05 Million
Q2 2023 Aug 01, 2023	BUY	$155.98 - $172.65 $137,106 - $151,759	879 Added 42.12%	2,966 $479,000
Q1 2023 May 05, 2023	SELL	$132.34 - $159.14 $40,893 - $49,174	-309 Reduced 12.9%	2,087 $332,000
Q4 2022 Jan 24, 2023	SELL	$102.55 - $135.33 $29,944 - $39,516	-292 Reduced 10.86%	2,396 $0
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $17,912 - $21,982	-188 Reduced 6.54%	2,688 $268,000
Q2 2022 Aug 11, 2022	BUY	$103.24 - $121.81 $44,599 - $52,621	432 Added 17.68%	2,876 $321,000
Q1 2022 Apr 20, 2022	SELL	$93.1 - $112.54 $2,234 - $2,700	-24 Reduced 0.97%	2,444 $271,000
Q4 2021 Feb 02, 2022	BUY	$95.88 - $117.08 $9,588 - $11,708	100 Added 4.22%	2,468 $276,000
Q3 2021 Oct 28, 2021	BUY	$84.42 - $106.62 $199,906 - $252,476	2,368 New	2,368 $227,000

Others Institutions Holding NVO

# of Institutions

1,867

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $132B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Novo Nordisk A S Transaction History